Illumina Company Profile (NASDAQ:ILMN)

About Illumina (NASDAQ:ILMN)

Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company's portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.

Industry, Sector and Symbol:

Sector: Medical
Industry: Biotechnology
Sub-Industry: Life Sciences Tools & Services
Symbol: NASDAQ:ILMN
CUSIP: 45232710
Web: www.illumina.com

Capitalization:

Market Cap: $25.68 billion
Outstanding Shares: 146,000,000

Average Prices:

50 Day Moving Avg: $179.07
200 Day Moving Avg: $157.94
52 Week Range: $119.37 - $189.48

P/E:

Trailing P/E Ratio: 35.60
Foreward P/E Ratio: 40.44
P/E Growth: 3.40

Sales & Book Value:

Annual Revenue: $2.42 billion
Price / Sales: 10.61
Book Value: $17.47 per share
Price / Book: 10.07

Profitability:

EBIDTA: $678.78 million
Net Margins: 19.31%
Return on Equity: 22.89%
Return on Assets: 12.37%

Debt:

Debt-to-Equity Ratio: 0.46%
Current Ratio: 3.29%
Quick Ratio: 2.86%

Misc:

Average Volume: 1.03 million shs.
Beta: 0.79
Short Ratio: 5.85

Frequently Asked Questions for Illumina (NASDAQ:ILMN)

What is Illumina's stock symbol?

Illumina trades on the NASDAQ under the ticker symbol "ILMN."

How were Illumina's earnings last quarter?

Illumina, Inc. (NASDAQ:ILMN) posted its earnings results on Tuesday, April, 25th. The company reported $0.64 earnings per share (EPS) for the quarter, meeting the Zacks' consensus estimate of $0.64. The firm earned $598 million during the quarter, compared to analysts' expectations of $590.51 million. Illumina had a net margin of 19.31% and a return on equity of 22.89%. The company's revenue was up 4.5% compared to the same quarter last year. During the same period in the previous year, the company earned $0.71 earnings per share. View Illumina's Earnings History.

What guidance has Illumina issued on next quarter's earnings?

Illumina issued an update on its FY17 earnings guidance on Tuesday, April, 25th. The company provided earnings per share guidance of $3.60-3.70 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.65. Illumina also updated its Q2 guidance to $0.65-0.70 EPS.

Where is Illumina's stock going? Where will Illumina's stock price be in 2017?

20 analysts have issued 12 month price objectives for Illumina's stock. Their predictions range from $115.00 to $200.00. On average, they expect Illumina's stock price to reach $161.92 in the next twelve months. View Analyst Ratings for Illumina.

Who are some of Illumina's key competitors?

Some companies that are related to Illumina include Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals Incorporated (VRTX), Grifols SA, Barcelona (GRFS), Incyte (INCY), Alexion Pharmaceuticals (ALXN), BioMarin Pharmaceutical (BMRN), Seattle Genetics (SGEN), Jazz Pharmaceuticals plc - (JAZZ), TESARO (TSRO), Alnylam Pharmaceuticals (ALNY), Exelixis (EXEL), BIO-TECHNE Corp (TECH), Kite Pharma (KITE), Galapagos NV (GLPG), Opko Health (OPK), Nektar Therapeutics (NKTR), bluebird bio (BLUE) and ACADIA Pharmaceuticals (ACAD).

Who owns Illumina stock?

Illumina's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Baillie Gifford & Co. (12.86%), Vanguard Group Inc. (6.61%), Edgewood Management LLC (4.13%), Jennison Associates LLC (3.59%), Ameriprise Financial Inc. (1.53%) and Primecap Management Co. CA (1.42%). Company insiders that own Illumina stock include A Blaine Bowman, Charles Dadswell, Christian O Henry, Daniel Bradbury, David R Walt, Frances Arnold, Jay T Flatley, Karin Eastham, Marc Stapley, Michel Bouchard, Mostafa Ronaghi, Nicholas Naclerio, Omead Ostadan, Paul L Bianchi, Robert S Epstein and Roy A Whitfield. View Institutional Ownership Trends for Illumina.

Who sold Illumina stock? Who is selling Illumina stock?

Illumina's stock was sold by a variety of institutional investors in the last quarter, including Edgewood Management LLC, Ameriprise Financial Inc., TCW Group Inc., First Trust Advisors LP, Commerzbank Aktiengesellschaft FI, DF Dent & Co. Inc., APG Asset Management N.V. and State of New Jersey Common Pension Fund D. Company insiders that have sold Illumina stock in the last year include A Blaine Bowman, Charles Dadswell, Christian O Henry, Daniel Bradbury, Frances Arnold, Jay T Flatley, Karin Eastham, Marc Stapley, Michel Bouchard, Omead Ostadan, Robert S Epstein and Roy A Whitfield. View Insider Buying and Selling for Illumina.

Who bought Illumina stock? Who is buying Illumina stock?

Illumina's stock was purchased by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Vanguard Group Inc., TIAA CREF Investment Management LLC, Baird Financial Group Inc., Teachers Advisors LLC, State Treasurer State of Michigan, Swiss National Bank and Geode Capital Management LLC. View Insider Buying and Selling for Illumina.

How do I buy Illumina stock?

Shares of Illumina can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Illumina stock cost?

One share of Illumina stock can currently be purchased for approximately $175.91.

Consensus Ratings for Illumina (NASDAQ:ILMN) (?)

Ratings Breakdown:	3 Sell Ratings, 9 Hold Ratings, 8 Buy Ratings
Consensus Rating:	Hold (Score: 2.25)
Consensus Price Target:	$161.92 (7.95% downside)

Analysts' Ratings History for Illumina (NASDAQ:ILMN)

Show:

Date	Firm	Action	Rating	Price Target	Impact on Share Price
5/15/2017	Morgan Stanley	Reiterated Rating	Underweight	$108.00 -> $115.00	Medium
4/29/2017	Deutsche Bank AG	Reiterated Rating	Hold	$165.00 -> $175.00	Low
4/26/2017	Cowen and Company	Reiterated Rating	Outperform	$200.00	High
4/26/2017	Cantor Fitzgerald	Boost Price Target	Neutral -> Neutral	$155.00 -> $170.00	High
4/14/2017	Piper Jaffray Companies	Reiterated Rating	Overweight	$170.00 -> $187.00	N/A
4/11/2017	Bank of America Corp	Boost Price Target	Buy	$175.00 -> $195.00	Low
4/5/2017	Leerink Swann	Reiterated Rating	Buy		Medium
3/19/2017	BTIG Research	Reiterated Rating	Hold		Medium
2/27/2017	Evercore ISI	Upgrade	Hold -> Buy	$190.00	N/A
2/21/2017	Canaccord Genuity	Reiterated Rating	Hold	$150.00	N/A
1/12/2017	Robert W. Baird	Reiterated Rating	Neutral	$147.00 -> $153.00	N/A
1/9/2017	Barclays PLC	Reiterated Rating	Equal Weight	$145.00	N/A
1/6/2017	Janney Montgomery Scott	Reiterated Rating	Neutral -> Sell	$125.00	N/A
1/6/2017	CL King	Upgrade	Neutral -> Buy		N/A
11/2/2016	First Analysis	Downgrade	Equal Weight -> Underweight	$130.00 -> $116.00	N/A
10/14/2016	Argus	Reiterated Rating	Buy	$205.00 -> $170.00	N/A
10/12/2016	Wells Fargo & Co	Reiterated Rating	Market Perform	$150.00 -> $137.50	N/A
10/11/2016	Citigroup Inc	Downgrade	Buy -> Neutral	$190.00 -> $140.00	N/A
7/27/2016	JPMorgan Chase & Co.	Boost Price Target	Overweight	$185.00 -> $200.00	N/A
7/27/2016	Mizuho	Boost Price Target	Neutral	$138.00 -> $148.00	N/A
5/4/2016	Stifel Nicolaus	Reiterated Rating	Buy	$215.00 -> $160.00	N/A
5/3/2016	Nomura	Lower Price Target	Buy	$210.00 -> $180.00	N/A
4/22/2016	Avondale Partners	Reiterated Rating	Market Perform	$175.00 -> $160.00	N/A
3/23/2016	Goldman Sachs Group Inc	Lower Price Target		$141.00	N/A
10/21/2015	Wedbush	Boost Price Target	Outperform	$150.00 -> $160.00	N/A
10/8/2015	William Blair	Reiterated Rating	Buy		N/A

(Data available from 5/26/2015 forward)

Earnings History for Illumina (NASDAQ:ILMN)

Earnings by Quarter for Illumina (NASDAQ:ILMN)

Earnings History by Quarter for Illumina (NASDAQ:ILMN)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
4/25/2017	Q1 2017	$0.64	$0.64	$590.51 million	$598.00 million	View	N/A
1/31/2017	Q416	$0.82	$0.85	$612.50 million	$619.00 million	View	Listen
11/1/2016	Q316	$0.87	$0.97	$628.06 million	$607.00 million	View	Listen
7/26/2016	Q2	$0.73	$0.86	$31.91 million	$600.00 million	View	Listen
5/3/2016	Q1	$0.74	$0.71	$596.33 million	$572.00 million	View	Listen
2/2/2016	Q415	$0.82	$0.81	$576.39 million	$591.50 million	View	Listen
10/20/2015	Q315	$0.79	$0.80	$568.60 million	$550.00 million	View	Listen
7/21/2015	Q215	$0.77	$0.80	$541.05 million	$539.00 million	View	Listen
4/21/2015	Q115	$0.72	$0.91	$524.35 million	$539.00 million	View	Listen
1/27/2015	Q414	$0.78	$0.87	$503.83 million	$512.00 million	View	Listen
10/20/2014	Q314	$0.56	$0.77	$451.20 million	$481.00 million	View	Listen
7/23/2014	Q214	$0.51	$0.57	$426.50 million	$448.00 million	View	Listen
4/22/2014	Q114	$0.44	$0.53	$391.50 million	$421.00 million	View	Listen
1/28/2014	Q413	$0.44	$0.45	$382.06 million	$387.00 million	View	Listen
10/21/2013	Q313	$0.40	$0.45	$343.42 million	$357.00 million	View	Listen
7/23/2013	Q2 2013	$0.40	$0.43	$331.77 million	$346.09 million	View	Listen
4/22/2013	Q1 2013	$0.39	$0.46	$310.64 million	$330.96 million	View	Listen
1/28/2013	Q4 2012	$0.41	$0.42	$303.13 million	$309.30 million	View	Listen
10/23/2012		$0.39	$0.41			View	N/A
7/24/2012		$0.36	$0.40			View	N/A
4/23/2012		$0.32	$0.36			View	N/A
2/7/2012		$0.30	$0.35			View	N/A
10/25/2011		$0.23	$0.22			View	N/A
4/26/2011		$0.31	$0.35			View	N/A
2/8/2011		$0.29	$0.29			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Illumina (NASDAQ:ILMN)

2017 EPS Consensus Estimate: $3.63
2018 EPS Consensus Estimate: $4.36

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2017	3	$0.63	$0.82	$0.69
Q2 2017	3	$0.65	$0.85	$0.72
Q3 2017	3	$0.95	$1.14	$1.06
Q4 2017	3	$1.04	$1.27	$1.16
Q1 2018	3	$0.76	$1.04	$0.94
Q2 2018	2	$1.05	$1.07	$1.06
Q3 2018	2	$1.12	$1.17	$1.15
Q4 2018	2	$1.17	$1.26	$1.22

(Data provided by Zacks Investment Research)

Dividend History for Illumina (NASDAQ:ILMN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading and Institutional Ownership History for Illumina (NASDAQ:ILMN)

Insider Ownership Percentage: 1.60%
Institutional Ownership Percentage: 92.79%

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Insider Trades by Quarter for Illumina (NASDAQ:ILMN)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
5/25/2017	Frances Arnold	Director	Sell	825	$174.77	$144,185.25
5/23/2017	Jay T Flatley	Director	Sell	15,000	$175.53	$2,632,950.00
5/10/2017	A Blaine Bowman	Director	Sell	2,300	$181.61	$417,703.00
5/9/2017	Jay T Flatley	Director	Sell	20,000	$184.14	$3,682,800.00
5/9/2017	Michel Bouchard	Insider	Sell	5,740	$184.68	$1,060,063.20
5/3/2017	Charles Dadswell	SVP	Sell	1,609	$187.07	$300,995.63
4/12/2017	A Blaine Bowman	Director	Sell	3,000	$172.72	$518,160.00
4/7/2017	Daniel Bradbury	Director	Sell	600	$172.79	$103,674.00
3/24/2017	Omead Ostadan	EVP	Sell	1,672	$170.00	$284,240.00
3/21/2017	Daniel Bradbury	Director	Sell	600	$163.56	$98,136.00
2/17/2017	Daniel Bradbury	Director	Sell	600	$162.80	$97,680.00
2/13/2017	Omead Ostadan	EVP	Sell	2,173	$163.10	$354,416.30
2/8/2017	A Blaine Bowman	Director	Sell	3,000	$162.74	$488,220.00
2/6/2017	Charles Dadswell	SVP	Sell	572	$161.26	$92,240.72
1/30/2017	Omead Ostadan	EVP	Sell	259	$160.90	$41,673.10
1/19/2017	Omead Ostadan	EVP	Sell	2,378	$160.06	$380,622.68
1/11/2017	A Blaine Bowman	Director	Sell	3,000	$162.89	$488,670.00
1/10/2017	Charles Dadswell	SVP	Sell	116	$161.60	$18,745.60
1/4/2017	Daniel Bradbury	Director	Sell	600	$135.01	$81,006.00
12/15/2016	Omead Ostadan	EVP	Sell	2,000	$126.16	$252,320.00
12/12/2016	Daniel Bradbury	Director	Sell	600	$123.42	$74,052.00
12/8/2016	Omead Ostadan	EVP	Sell	3,000	$121.63	$364,890.00
12/1/2016	Omead Ostadan	EVP	Sell	3,000	$133.30	$399,900.00
11/14/2016	Daniel Bradbury	Director	Sell	600	$136.34	$81,804.00
10/7/2016	Daniel Bradbury	Director	Sell	600	$184.36	$110,616.00
10/4/2016	Charles Dadswell	SVP	Sell	116	$182.38	$21,156.08
9/20/2016	Robert S Epstein	Director	Sell	300	$174.29	$52,287.00
9/15/2016	Marc Stapley	EVP	Sell	1,270	$172.87	$219,544.90
9/14/2016	Daniel Bradbury	Director	Sell	600	$171.25	$102,750.00
8/23/2016	Jay T Flatley	Director	Sell	20,000	$172.99	$3,459,800.00
8/22/2016	Robert S Epstein	Director	Sell	300	$170.27	$51,081.00
8/17/2016	Daniel Bradbury	Director	Sell	600	$168.42	$101,052.00
8/15/2016	Jay T Flatley	Director	Sell	10,000	$170.00	$1,700,000.00
8/12/2016	Roy A Whitfield	Director	Sell	4,000	$167.22	$668,880.00
8/9/2016	Jay T Flatley	Director	Sell	10,000	$165.97	$1,659,700.00
8/1/2016	Jay T Flatley	Director	Sell	10,000	$170.00	$1,700,000.00
7/27/2016	Charles Dadswell	SVP	Sell	8,632	$155.00	$1,337,960.00
7/26/2016	Jay T Flatley	Director	Sell	10,000	$150.00	$1,500,000.00
7/20/2016	Robert S Epstein	Director	Sell	1,200	$150.00	$180,000.00
7/18/2016	Jay T Flatley	Director	Sell	10,000	$150.00	$1,500,000.00
7/14/2016	A Blaine Bowman	Director	Sell	5,000	$147.14	$735,700.00
7/11/2016	Christian O Henry	EVP	Sell	716	$141.89	$101,593.24
6/16/2016	A Blaine Bowman	Director	Sell	5,000	$135.08	$675,400.00
6/15/2016	Christian O Henry	EVP	Sell	2,141	$137.90	$295,243.90
6/13/2016	Roy A Whitfield	Director	Sell	3,800	$140.44	$533,672.00
6/1/2016	Karin Eastham	Director	Sell	5,000	$145.35	$726,750.00
5/25/2016	Christian O Henry	EVP	Sell	2,141	$144.73	$309,866.93
5/17/2016	Christian O Henry	EVP	Sell	2,141	$140.84	$301,538.44
5/12/2016	A Blaine Bowman	Director	Sell	5,000	$137.11	$685,550.00
4/27/2016	Christian O Henry	EVP	Sell	2,141	$138.46	$296,442.86
4/18/2016	Christian O Henry	EVP	Sell	2,141	$176.01	$376,837.41
4/18/2016	Paul L Bianchi	VP	Sell	1,884	$175.00	$329,700.00
4/14/2016	A Blaine Bowman	Director	Sell	5,000	$172.94	$864,700.00
4/13/2016	Christian O Henry	EVP	Sell	12,500	$175.00	$2,187,500.00
4/13/2016	Paul L Bianchi	VP	Sell	6,681	$175.00	$1,169,175.00
4/12/2016	Jay T Flatley	CEO	Sell	20,000	$170.05	$3,401,000.00
4/12/2016	Roy A Whitfield	Director	Sell	4,000	$170.00	$680,000.00
4/7/2016	David R Walt	Director	Sell	4,000	$168.90	$675,600.00
4/5/2016	Christian O Henry	EVP	Sell	2,141	$166.07	$355,555.87
4/4/2016	Charles Dadswell	SVP	Sell	8,382	$167.81	$1,406,583.42
3/23/2016	Christian O Henry	EVP	Sell	2,141	$155.05	$331,962.05
3/22/2016	Jay T Flatley	CEO	Sell	10,000	$154.18	$1,541,800.00
3/21/2016	Daniel Bradbury	Director	Sell	1,200	$155.63	$186,756.00
3/21/2016	Nicholas Naclerio	SVP	Sell	4,520	$154.25	$697,210.00
3/17/2016	A Blaine Bowman	Director	Sell	5,000	$145.24	$726,200.00
3/15/2016	David R Walt	Director	Sell	4,000	$149.99	$599,960.00
3/14/2016	Christian O Henry	EVP	Sell	5,892	$155.91	$918,621.72
3/8/2016	Charles Dadswell	SVP	Sell	8,382	$155.63	$1,304,490.66
3/8/2016	Jay T Flatley	CEO	Sell	10,000	$154.49	$1,544,900.00
3/8/2016	Omead Ostadan	EVP	Sell	4,516	$156.09	$704,902.44
3/7/2016	Charles Dadswell	SVP	Sell	116	$155.00	$17,980.00
2/23/2016	Jay T Flatley	CEO	Sell	10,000	$152.49	$1,524,900.00
2/17/2016	Daniel Bradbury	Director	Sell	1,700	$154.74	$263,058.00
2/12/2016	Roy A. Whitfield	Director	Sell	3,750	$140.30	$526,125.00
2/1/2016	Omead Ostadan	EVP	Sell	1,108	$156.73	$173,656.84
1/26/2016	Jay T. Flatley	CEO	Sell	20,000	$171.70	$3,434,000.00
1/13/2016	Jay T. Flatley	CEO	Sell	20,000	$168.81	$3,376,200.00
1/4/2016	Daniel Bradbury	Director	Sell	1,700	$182.80	$310,760.00
12/28/2015	Charles Dadswell	SVP	Sell	168	$188.63	$31,689.84
12/22/2015	Jay T. Flatley	CEO	Sell	25,000	$185.38	$4,634,500.00
12/14/2015	Roy A. Whitfield	Director	Sell	3,750	$175.07	$656,512.50
12/11/2015	Omead Ostadan	EVP	Sell	260	$179.90	$46,774.00
12/11/2015	Paul L Bianchi	VP	Sell	197	$179.90	$35,440.30
12/10/2015	Daniel Bradbury	Director	Sell	1,700	$182.37	$310,029.00
12/8/2015	Jay T. Flatley	CEO	Sell	25,000	$177.11	$4,427,750.00
11/27/2015	Robert S Epstein	Director	Sell	1,000	$185.56	$185,560.00
11/25/2015	Jay T. Flatley	CEO	Sell	5,000	$180.00	$900,000.00
11/24/2015	Jay T. Flatley	CEO	Sell	20,000	$173.27	$3,465,400.00
11/16/2015	Jay T. Flatley	CEO	Sell	10,000	$170.00	$1,700,000.00
11/10/2015	Daniel Bradbury	Director	Sell	1,700	$154.03	$261,851.00
11/10/2015	Jay T. Flatley	CEO	Sell	10,000	$154.58	$1,545,800.00
11/3/2015	Charles Dadswell	SVP	Sell	158	$150.00	$23,700.00
10/15/2015	Jay T. Flatley	CEO	Sell	10,000	$150.00	$1,500,000.00
10/7/2015	Daniel Bradbury	Director	Sell	1,700	$145.81	$247,877.00
9/29/2015	David R Walt	Director	Sell	2,000	$171.65	$343,300.00
9/22/2015	Jay T. Flatley	CEO	Sell	25,000	$192.79	$4,819,750.00
9/15/2015	David R Walt	Director	Sell	2,000	$206.45	$412,900.00
9/14/2015	Daniel Bradbury	Director	Sell	1,700	$203.89	$346,613.00
9/9/2015	Paul L. Bianchi	VP	Sell	1,245	$199.32	$248,153.40
9/8/2015	Jay T. Flatley	CEO	Sell	25,000	$194.87	$4,871,750.00
9/8/2015	Karin Eastham	Director	Sell	4,300	$195.76	$841,768.00
9/4/2015	Roy A. Whitfield	Director	Sell	4,500	$192.63	$866,835.00
9/1/2015	David R Walt	Director	Sell	2,000	$195.08	$390,160.00
8/27/2015	Jay T. Flatley	CEO	Sell	25,000	$200.16	$5,004,000.00
8/18/2015	David R Walt	Director	Sell	2,000	$206.89	$413,780.00
8/17/2015	Daniel Bradbury	Director	Sell	1,700	$208.14	$353,838.00
8/13/2015	Jay T Flatley	CEO	Sell	25,000	$207.85	$5,196,250.00
8/5/2015	Roy A. Whitfield	Director	Sell	4,500	$215.22	$968,490.00
7/24/2015	A Blaine Bowman	Director	Sell	3,000	$221.47	$664,410.00
7/23/2015	Jay T Flatley	CEO	Sell	25,000	$214.87	$5,371,750.00
7/21/2015	David R Walt	Director	Sell	12,000	$235.24	$2,822,880.00
7/17/2015	Mostafa Ronaghi	SVP	Sell	1,200	$235.00	$282,000.00
7/16/2015	Christian O Henry	SVP	Sell	5,390	$229.61	$1,237,597.90
7/15/2015	Mostafa Ronaghi	SVP	Sell	3,000	$227.19	$681,570.00
7/14/2015	David R Walt	Director	Sell	10,000	$227.39	$2,273,900.00
7/13/2015	Marc Stapley	CFO	Sell	3,000	$214.90	$644,700.00
7/13/2015	Michel Bouchard	CAO	Sell	1,400	$222.75	$311,850.00
7/10/2015	Omead Ostadan	SVP	Sell	1,110	$219.81	$243,989.10
7/10/2015	Robert S Epstein	Director	Sell	2,000	$219.81	$439,620.00
7/9/2015	Jay T Flatley	CEO	Sell	25,000	$218.10	$5,452,500.00
7/7/2015	David R Walt	Director	Sell	10,000	$220.22	$2,202,200.00
7/6/2015	Daniel Bradbury	Director	Sell	1,700	$219.70	$373,490.00
6/30/2015	David R Walt	Director	Sell	10,000	$217.64	$2,176,400.00
6/25/2015	Jay T Flatley	CEO	Sell	25,000	$220.34	$5,508,500.00
6/24/2015	A Blaine Bowman	Director	Sell	3,000	$221.43	$664,290.00
6/24/2015	Christian O Henry	SVP	Sell	5,084	$221.07	$1,123,919.88
6/23/2015	David R Walt	Director	Sell	12,000	$220.11	$2,641,320.00
6/17/2015	Christian O Henry	SVP	Sell	3,751	$215.71	$809,128.21
6/16/2015	David R Walt	Director	Sell	10,000	$215.14	$2,151,400.00
6/15/2015	Nicholas Naclerio	SVP	Sell	6,590	$214.33	$1,412,434.70
6/15/2015	Paul L Bianchi	VP	Sell	3,408	$215.83	$735,548.64
6/12/2015	Marc Stapley	CFO	Sell	3,000	$214.90	$644,700.00
6/12/2015	Michel Bouchard	CAO	Sell	1,400	$216.11	$302,554.00
6/11/2015	Jay T Flatley	CEO	Sell	25,000	$216.41	$5,410,250.00
6/10/2015	Christian O Henry	SVP	Sell	10,000	$214.94	$2,149,400.00
6/10/2015	Robert S Epstein	Director	Sell	2,000	$214.24	$428,480.00
6/5/2015	Roy A Whitfield	Director	Sell	4,500	$207.49	$933,705.00
6/2/2015	David R Walt	Director	Sell	10,000	$204.42	$2,044,200.00
6/1/2015	Karin Eastham	Director	Sell	5,000	$205.24	$1,026,200.00
5/29/2015	Daniel Bradbury	Director	Sell	1,700	$206.62	$351,254.00
5/28/2015	Jay T Flatley	CEO	Sell	25,000	$208.78	$5,219,500.00
5/22/2015	A Blaine Bowman	Director	Sell	3,000	$204.58	$613,740.00
5/19/2015	David R Walt	Director	Sell	10,000	$202.00	$2,020,000.00
5/14/2015	Christian O Henry	SVP	Sell	3,751	$198.52	$744,648.52
5/14/2015	Jay T Flatley	CEO	Sell	25,000	$197.76	$4,944,000.00
5/13/2015	Paul L Bianchi	VP	Sell	3,356	$197.14	$661,601.84
5/11/2015	Robert S Epstein	Director	Sell	2,000	$196.49	$392,980.00
4/28/2015	David R Walt	Director	Sell	7,000	$183.88	$1,287,160.00
4/24/2015	A Blaine Bowman	Director	Sell	3,000	$190.73	$572,190.00
4/23/2015	Jay T Flatley	CEO	Sell	25,000	$189.57	$4,739,250.00
4/21/2015	David R Walt	Director	Sell	10,000	$197.95	$1,979,500.00
4/15/2015	Christian O Henry	SVP	Sell	3,751	$189.02	$709,014.02
4/14/2015	David R Walt	Director	Sell	7,000	$188.23	$1,317,610.00
4/13/2015	Marc Stapley	CFO	Sell	3,000	$190.12	$570,360.00
4/13/2015	Michel Bouchard	CAO	Sell	1,400	$188.61	$264,054.00
4/13/2015	Paul L Bianchi	VP	Sell	3,390	$187.22	$634,675.80
4/10/2015	Robert S Epstein	Director	Sell	2,000	$186.99	$373,980.00
4/9/2015	Jay T Flatley	CEO	Sell	25,000	$184.55	$4,613,750.00
4/8/2015	Daniel Bradbury	Director	Sell	1,700	$185.32	$315,044.00
4/7/2015	David R Walt	Director	Sell	5,000	$184.28	$921,400.00
4/6/2015	Roy A Whitfield	Director	Sell	4,600	$181.32	$834,072.00
3/26/2015	Jay T Flatley	CEO	Sell	25,000	$181.34	$4,533,500.00
3/24/2015	David R Walt	Director	Sell	5,000	$192.16	$960,800.00
3/17/2015	A Blaine Bowman	Director	Sell	3,000	$192.30	$576,900.00
3/16/2015	Gerald Moeller	Director	Sell	2,700	$193.36	$522,072.00
3/16/2015	Nicholas Naclerio	SVP	Sell	6,590	$193.94	$1,278,064.60
3/13/2015	Paul L Bianchi	VP	Sell	3,390	$186.67	$632,811.30
3/12/2015	Marc Stapley	CFO	Sell	3,314	$189.01	$626,379.14
3/10/2015	Richard Klausner	SVP	Sell	1,186	$191.75	$227,415.50
3/10/2015	Robert S Epstein	Director	Sell	3,000	$191.75	$575,250.00
2/26/2015	Jay T Flatley	CEO	Sell	25,000	$195.73	$4,893,250.00
2/12/2015	Jay T Flatley	CEO	Sell	25,000	$194.64	$4,866,000.00
2/3/2015	David R Walt	Director	Sell	7,000	$190.89	$1,336,230.00
2/2/2015	Karin Eastham	Director	Sell	10,000	$192.77	$1,927,700.00
2/2/2015	Nicholas Naclerio	SVP	Sell	15,250	$194.37	$2,964,142.50
1/27/2015	Charles Dadswell	SVP	Sell	224	$198.90	$44,553.60
1/27/2015	David R Walt	Director	Sell	4,000	$201.76	$807,040.00
1/22/2015	Jay T Flatley	CEO	Sell	25,000	$188.48	$4,712,000.00
1/20/2015	William H Rastetter	Director	Sell	16,000	$188.99	$3,023,840.00
1/15/2015	Marc Stapley	CFO	Sell	1,422	$181.62	$258,263.64
1/8/2015	Jay T Flatley	CEO	Sell	25,000	$197.62	$4,940,500.00
1/6/2015	David R Walt	Director	Sell	6,000	$188.55	$1,131,300.00
1/2/2015	Karin Eastham	Director	Sell	10,000	$185.63	$1,856,300.00
12/30/2014	David R Walt	Director	Sell	5,000	$186.95	$934,750.00
12/29/2014	Gerald Moeller	Director	Sell	8,000	$187.05	$1,496,400.00
12/26/2014	Jay T Flatley	CEO	Sell	25,000	$186.71	$4,667,750.00
12/23/2014	David R Walt	Director	Sell	7,000	$184.55	$1,291,850.00
12/16/2014	David R Walt	Director	Sell	5,000	$178.35	$891,750.00
12/15/2014	Marc Stapley	CFO	Sell	1,422	$181.09	$257,509.98
12/11/2014	Jay T Flatley	CEO	Sell	25,000	$185.79	$4,644,750.00
12/9/2014	David R Walt	Director	Sell	7,000	$186.75	$1,307,250.00
12/8/2014	Daniel Bradbury	Director	Sell	1,600	$190.14	$304,224.00
12/4/2014	Karin Eastham	Director	Sell	10,000	$191.87	$1,918,700.00
12/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$188.46	$1,884,600.00
11/26/2014	Paul L Bianchi	SVP	Sell	1,626	$189.20	$307,639.20
11/17/2014	Roy A Whitfield	Director	Sell	4,000	$178.26	$713,040.00
11/14/2014	Marc Stapley	CFO	Sell	1,422	$181.13	$257,566.86
11/13/2014	Daniel Bradbury	Director	Sell	2,100	$186.88	$392,448.00
11/13/2014	Jay T Flatley	CEO	Sell	25,000	$189.32	$4,733,000.00
11/3/2014	Michel Bouchard	CAO	Sell	631	$195.68	$123,474.08
11/3/2014	Mostafa Ronaghi	SVP	Sell	10,000	$195.66	$1,956,600.00
10/30/2014	Daniel Bradbury	Director	Sell	2,100	$191.83	$402,843.00
10/23/2014	Jay T Flatley	CEO	Sell	25,000	$189.54	$4,738,500.00
10/13/2014	Daniel Bradbury	Director	Sell	2,100	$152.03	$319,263.00
10/9/2014	Jay T Flatley	CEO	Sell	25,000	$163.49	$4,087,250.00
10/7/2014	A Blaine Bowman	Director	Sell	4,456	$159.51	$710,776.56
10/1/2014	Daniel Bradbury	Director	Sell	2,100	$158.88	$333,648.00
10/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$159.81	$1,598,100.00
9/30/2014	A Blaine Bowman	Director	Sell	5,000	$164.02	$820,100.00
9/29/2014	Gerald Moeller	Director	Sell	5,000	$164.89	$824,450.00
9/25/2014	Jay T Flatley	CEO	Sell	25,000	$164.43	$4,110,750.00
9/24/2014	Christian O Henry	SVP	Sell	20,000	$167.28	$3,345,600.00
9/23/2014	A Blaine Bowman	Director	Sell	5,000	$168.50	$842,500.00
9/16/2014	A Blaine Bowman	Director	Sell	5,000	$169.60	$848,000.00
9/15/2014	Daniel Bradbury	Director	Sell	2,100	$168.57	$353,997.00
9/15/2014	Jay T Flatley	CEO	Sell	25,000	$176.06	$4,401,500.00
9/15/2014	Marc Stapley	CFO	Sell	1,422	$169.05	$240,389.10
9/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$169.53	$339,060.00
9/9/2014	A Blaine Bowman	Director	Sell	5,000	$178.08	$890,400.00
9/3/2014	Christian O Henry	SVP	Sell	10,000	$180.59	$1,805,900.00
9/3/2014	Daniel Bradbury	Director	Sell	2,100	$179.77	$377,517.00
9/2/2014	A Blaine Bowman	Director	Sell	5,000	$179.67	$898,350.00
9/2/2014	Michel Bouchard	VP	Sell	686	$180.07	$123,528.02
9/2/2014	Mostafa Ronaghi	SVP	Sell	10,000	$179.66	$1,796,600.00
8/28/2014	Jay T Flatley	CEO	Sell	30,000	$178.98	$5,369,400.00
8/26/2014	A Blaine Bowman	Director	Sell	5,000	$179.22	$896,100.00
8/22/2014	Daniel Bradbury	Director	Sell	2,100	$172.24	$361,704.00
8/19/2014	A Blaine Bowman	Director	Sell	5,000	$171.70	$858,500.00
8/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$167.23	$334,460.00
8/15/2014	Roy A Whitfield	Director	Sell	4,000	$169.28	$677,120.00
8/13/2014	Christian O Henry	SVP	Sell	20,000	$164.66	$3,293,200.00
8/5/2014	A Blaine Bowman	Director	Sell	5,000	$159.91	$799,550.00
8/4/2014	Daniel Bradbury	Director	Sell	2,100	$159.77	$335,517.00
8/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$159.73	$1,597,300.00
7/29/2014	A Blaine Bowman	Director	Sell	5,000	$166.89	$834,450.00
7/29/2014	Christian O Henry	SVP	Sell	10,000	$167.40	$1,674,000.00
7/24/2014	Jay T Flatley	CEO	Sell	30,000	$175.43	$5,262,900.00
7/23/2014	Daniel Bradbury	Director	Sell	2,100	$177.87	$373,527.00
7/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$174.26	$348,520.00
7/14/2014	Marc Stapley	CFO	Sell	1,422	$177.59	$252,532.98
7/10/2014	Jay T Flatley	CEO	Sell	30,000	$172.56	$5,176,800.00
7/8/2014	Daniel Bradbury	Director	Sell	2,100	$172.89	$363,069.00
7/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$179.47	$1,794,700.00
6/30/2014	Gerald Moeller	Director	Sell	5,000	$178.97	$894,850.00
6/27/2014	Daniel Bradbury	Director	Sell	2,100	$171.65	$360,465.00
6/26/2014	Jay T Flatley	CEO	Sell	30,000	$170.11	$5,103,300.00
6/24/2014	Christian O Henry	SVP	Sell	10,000	$172.60	$1,726,000.00
6/16/2014	Christian O Henry	SVP	Sell	20,000	$169.73	$3,394,600.00
6/16/2014	Marc Stapley	CFO	Sell	1,422	$169.25	$240,673.50
6/12/2014	Daniel Bradbury	Director	Sell	2,100	$171.17	$359,457.00
6/12/2014	Jay T Flatley	CEO	Sell	30,000	$172.25	$5,167,500.00
6/2/2014	Karin Eastham	Director	Sell	6,000	$157.56	$945,360.00
6/2/2014	Michel Bouchard	CAO	Sell	1,491	$155.51	$231,865.41
6/2/2014	Mostafa Ronaghi	SVP	Sell	10,000	$156.93	$1,569,300.00
5/22/2014	Jay Flatley	CEO	Sell	30,000	$154.95	$4,648,500.00
5/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$141.72	$283,440.00
5/15/2014	Roy Whitfield	Director	Sell	4,000	$143.71	$574,840.00
5/14/2014	Daniel Bradbury	Director	Sell	2,100	$146.46	$307,566.00
5/14/2014	Marc Stapley	CFO	Sell	1,422	$146.94	$208,948.68
5/8/2014	Jay Flatley	CEO	Sell	30,000	$143.59	$4,307,700.00
5/2/2014	Daniel Bradbury	Director	Sell	2,100	$139.66	$293,286.00
5/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$135.91	$1,359,100.00
4/24/2014	Jay Flatley	CEO	Sell	30,000	$150.80	$4,524,000.00
4/15/2014	Daniel Bradbury	Director	Sell	2,100	$131.29	$275,709.00
4/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$133.56	$267,120.00
4/14/2014	Marc Stapley	CFO	Sell	1,422	$134.80	$191,685.60
4/10/2014	Jay Flatley	CEO	Sell	30,000	$139.90	$4,197,000.00
4/4/2014	Daniel Bradbury	Director	Sell	2,100	$138.44	$290,724.00
4/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$152.41	$1,524,100.00
3/27/2014	Jay Flatley	CEO	Sell	30,000	$140.11	$4,203,300.00
3/19/2014	Daniel Bradbury	Director	Sell	2,100	$161.14	$338,394.00
3/17/2014	Gerald Moeller	Director	Sell	10,000	$161.92	$1,619,200.00
3/17/2014	Nicholas Naclerio	SVP	Sell	2,000	$163.65	$327,300.00
3/14/2014	Marc Stapley	CFO	Sell	1,422	$163.35	$232,283.70
3/13/2014	Jay Flatley	CEO	Sell	30,000	$165.96	$4,978,800.00
3/11/2014	Christian Henry	SVP	Sell	3,000	$167.16	$501,480.00
3/11/2014	Michel Bouchard	CAO	Sell	2,168	$167.21	$362,511.28
3/3/2014	Michel Bouchard	CAO	Sell	2,994	$176.81	$529,369.14
2/25/2014	Michel Bouchard	CAO	Sell	24,505	$176.13	$4,316,065.65
2/24/2014	Roy Whitfield	Director	Sell	2,000	$175.26	$350,520.00
2/18/2014	Nicholas Naclerio	SVP	Sell	2,000	$169.77	$339,540.00
2/13/2014	Jay Flatley	CEO	Sell	30,000	$160.43	$4,812,900.00
2/7/2014	Jay Flatley	CEO	Sell	5,000	$152.23	$761,150.00
1/31/2014	Marc Stapley	CFO	Sell	20,038	$151.32	$3,032,150.16
1/23/2014	Jay Flatley	CEO	Sell	30,000	$142.30	$4,269,000.00
1/9/2014	Jay Flatley	CEO	Sell	30,000	$114.77	$3,443,100.00
12/26/2013	Jay Flatley	CEO	Sell	30,000	$107.88	$3,236,400.00
12/17/2013	Gregory Heath	SVP	Sell	1,875	$102.68	$192,525.00
10/30/2013	Christian O Henry	SVP	Sell	6,000	$93.29	$559,740.00
10/30/2013	David R Walt	Director	Sell	5,000	$93.02	$465,100.00
10/28/2013	William H Rastetter	Director	Sell	20,000	$92.37	$1,847,400.00
10/24/2013	Jay T Flatley	CEO	Sell	30,000	$92.32	$2,769,600.00
10/22/2013	Nicholas Naclerio	SVP	Sell	20,000	$90.00	$1,800,000.00
10/17/2013	Gregory Heath	SVP	Sell	1,875	$82.09	$153,918.75
10/16/2013	David R Walt	Director	Sell	5,000	$82.59	$412,950.00
10/15/2013	Nicholas Naclerio	SVP	Sell	4,000	$81.32	$325,280.00
10/10/2013	Christian Henry	SVP	Sell	6,000	$77.73	$466,380.00
10/10/2013	Jay Flatley	CEO	Sell	20,000	$77.75	$1,555,000.00
10/2/2013	David R Walt	Director	Sell	5,000	$80.58	$402,900.00
9/18/2013	David Walt	Director	Sell	5,000	$83.11	$415,550.00
9/17/2013	Gregory Heath	SVP	Sell	1,875	$85.20	$159,750.00
9/16/2013	Jay Flatley	CEO	Sell	30,000	$83.27	$2,498,100.00
9/16/2013	Nicholas Naclerio	SVP	Sell	4,000	$85.00	$340,000.00
9/10/2013	Gregory Heath	SVP	Sell	1,875	$82.00	$153,750.00
9/9/2013	Paul L Bianchi	SVP	Sell	1,627	$79.03	$128,581.81
9/5/2013	Christian O Henry	SVP	Sell	9,000	$78.17	$703,530.00
9/4/2013	David R Walt	Director	Sell	5,000	$77.18	$385,900.00
9/3/2013	Nicholas Naclerio	SVP	Sell	59,000	$76.91	$4,537,690.00
9/3/2013	Roy A Whitfield	Director	Sell	2,000	$78.49	$156,980.00
8/30/2013	Mark Lewis	SVP	Sell	5,000	$78.12	$390,600.00
8/22/2013	Jay Flatley	CEO	Sell	20,000	$78.65	$1,573,000.00
8/21/2013	David Walt	Director	Sell	5,000	$78.34	$391,700.00
8/15/2013	Nicholas Naclerio	SVP	Sell	2,000	$78.43	$156,860.00
8/8/2013	Jay Flatley	CEO	Sell	20,000	$78.07	$1,561,400.00
8/7/2013	David Walt	Director	Sell	5,000	$78.29	$391,450.00
8/2/2013	Michel Bouchard	VP	Sell	11,465	$80.64	$924,537.60
7/25/2013	Christian O Henry	SVP	Sell	11,462	$80.89	$927,161.18
7/25/2013	Jay T Flatley	CEO	Sell	20,000	$81.01	$1,620,200.00
7/24/2013	David R Walt	Director	Sell	4,600	$81.44	$374,624.00
7/24/2013	Gregory Heath	SVP	Sell	209,533	$82.00	$17,181,706.00
7/24/2013	Michel Bouchard	VP	Sell	9,789	$79.28	$776,071.92
7/15/2013	Nicholas Naclerio	SVP	Sell	2,000	$74.50	$149,000.00
7/11/2013	Jay T Flatley	CEO	Sell	20,000	$74.90	$1,498,000.00
7/11/2013	Mostafa Ronaghi	SVP	Sell	24,000	$74.95	$1,798,800.00
7/10/2013	David R Walt	Director	Sell	5,000	$74.26	$371,300.00
7/10/2013	Michel Bouchard	VP	Sell	3,618	$74.30	$268,817.40
7/9/2013	Christian O Henry	SVP	Sell	9,000	$74.01	$666,090.00
6/27/2013	Jay T Flatley	CEO	Sell	20,000	$74.96	$1,499,200.00
6/26/2013	David R Walt	Director	Sell	5,000	$75.36	$376,800.00
6/26/2013	Michel Bouchard	VP	Sell	4,272	$75.06	$320,656.32
6/25/2013	Tristan Orpin	SVP	Sell	35,000	$71.98	$2,519,300.00
6/17/2013	Nicholas Naclerio	SVP	Sell	2,000	$68.56	$137,120.00
6/14/2013	Christian O Henry	SVP	Sell	25,959	$68.10	$1,767,807.90
6/13/2013	Jay T Flatley	CEO	Sell	20,000	$66.49	$1,329,800.00
6/13/2013	Tristan Orpin	SVP	Sell	47,667	$66.55	$3,172,238.85
6/12/2013	David R Walt	Director	Sell	5,000	$67.67	$338,350.00
6/12/2013	Michel Bouchard	VP	Sell	5,170	$68.64	$354,868.80
6/11/2013	Mostafa Ronaghi	SVP	Sell	24,000	$69.01	$1,656,240.00
6/3/2013	Karin Eastham	Director	Sell	10,000	$70.34	$703,400.00
5/31/2013	Mark L Lewis	SVP	Sell	13,000	$71.72	$932,360.00
5/30/2013	Matthew L Posard	SVP	Sell	2,836	$70.80	$200,788.80
5/29/2013	David R Walt	Director	Sell	5,000	$70.92	$354,600.00
5/29/2013	Michel Bouchard	VP	Sell	6,276	$71.02	$445,721.52
5/21/2013	Jay T Flatley	CEO	Sell	24,000	$69.39	$1,665,360.00
5/20/2013	Marc Stapley	CFO	Sell	2,843	$73.38	$208,619.34
5/15/2013	David R Walt	Director	Sell	5,000	$70.73	$353,650.00
5/15/2013	Michel Bouchard	VP	Sell	14,241	$70.71	$1,006,981.11
5/15/2013	Nicholas Naclerio	SVP	Sell	2,000	$70.72	$141,440.00
5/13/2013	Mostafa Ronaghi	SVP	Sell	24,000	$68.83	$1,651,920.00
5/10/2013	Tristan Orpin	SVP	Sell	25,000	$69.60	$1,740,000.00
5/9/2013	Jay T Flatley	CEO	Sell	20,000	$66.63	$1,332,600.00
5/7/2013	Tristan Orpin	SVP	Sell	5,000	$65.68	$328,400.00
4/8/2013	Christian Cabou	SVP	Sell	16,500	$55.00	$907,500.00
4/8/2013	Marc Stapley	CFO	Sell	9,175	$55.00	$504,625.00
4/8/2013	William H Rastetter	Director	Sell	20,000	$54.95	$1,099,000.00
3/11/2013	Marc Stapley	CFO	Sell	4,468	$53.71	$239,976.28
11/8/2012	Jay T Flatley	CEO	Sell	5,000	$47.99	$239,950.00

(Data available from 1/1/2013 forward)

Headline Trends for Illumina (NASDAQ:ILMN) Latest Headlines for Illumina (NASDAQ:ILMN)

Source:

Date	Headline
	Insider Selling: Illumina, Inc. (ILMN) Director Sells 825 Shares of Stock www.americanbankingnews.com - May 26 at 8:02 PM
	Insider Selling: Illumina, Inc. (ILMN) Director Sells 15,000 Shares of Stock www.americanbankingnews.com - May 25 at 7:26 PM
	Start-up Genome Medical is training experts to help you figure out what your genetic tests mean finance.yahoo.com - May 24 at 11:34 AM
	Illumina CEO: When you invest in health research you actu... finance.yahoo.com - May 22 at 5:22 PM
	Illumina, Inc. (ILMN) Receives Average Recommendation of "Hold" from Analysts www.americanbankingnews.com - May 22 at 2:17 PM
	Illumina Names Mark Van Oene Chief Commercial Officer, Sales Leader Brings Genomics Expertise and Strong Commercial Leadership Experience to the Role finance.yahoo.com - May 22 at 10:50 AM
	Illumina, Inc. (ILMN) Upgraded to Strong-Buy by Vetr Inc. www.americanbankingnews.com - May 18 at 12:21 AM
	Illumina, Inc. (ILMN) Rating Reiterated by Morgan Stanley www.americanbankingnews.com - May 15 at 6:58 PM
	Insider Selling: Illumina, Inc. (ILMN) Director Sells 2,300 Shares of Stock www.americanbankingnews.com - May 12 at 10:50 PM
	Jay T. Flatley Sells 20,000 Shares of Illumina, Inc. (ILMN) Stock www.americanbankingnews.com - May 11 at 7:22 PM
	Illumina, Inc. (ILMN) Insider Michel Bouchard Sells 5,740 Shares www.americanbankingnews.com - May 10 at 10:44 PM
	The Two Reasons Why Illumina Rose 8.3% In April finance.yahoo.com - May 10 at 6:23 PM
	Cramer: These Sectors Look Bullish (Part III) finance.yahoo.com - May 8 at 5:31 PM
	Illumina, Inc. (ILMN) SVP Charles Dadswell Sells 1,609 Shares www.americanbankingnews.com - May 5 at 10:57 PM
	Illumina to Webcast Live Presentation at the Bank of America Merrill Lynch Health Care Conference finance.yahoo.com - May 4 at 6:04 PM
	Pulse 2017 Welcomes Over 4000 Customer Success Leaders to the Industry's Biggest Stage feeds.benzinga.com - May 3 at 12:13 PM
	Illumina (ILMN) Earning Somewhat Positive News Coverage, Analysis Shows www.americanbankingnews.com - May 2 at 7:54 PM
	Deutsche Bank AG Reiterates "Hold" Rating for Illumina, Inc. (ILMN) www.americanbankingnews.com - April 29 at 9:20 PM
	Illumina (ILMN) Given Daily Media Sentiment Score of 0.11 www.americanbankingnews.com - April 29 at 6:11 PM
	$642.58 Million in Sales Expected for Illumina, Inc. (ILMN) This Quarter www.americanbankingnews.com - April 29 at 10:16 AM
	Illumina, Inc. (ILMN) Forecasted to Earn Q2 2017 Earnings of $0.66 Per Share www.americanbankingnews.com - April 28 at 7:54 AM
	Leerink Swann Research Analysts Decrease Earnings Estimates for Illumina, Inc. (ILMN) www.americanbankingnews.com - April 28 at 7:54 AM
	Illumina Inc. (ILMN) Is Losing Ground After Q1 Report www.rttnews.com - April 27 at 6:27 PM
	Illumina Inc. Meets Earnings Expectations Thanks to Solid Service Revenue Growth finance.yahoo.com - April 27 at 6:27 PM
	Here's Why Pacific Biosciences of California Is Sliding Today finance.yahoo.com - April 27 at 6:27 PM
	Q4 2017 EPS Estimates for Illumina, Inc. Lifted by Analyst (ILMN) www.americanbankingnews.com - April 27 at 2:58 PM
	Illumina, Inc. to Post Q3 2017 Earnings of $1.14 Per Share, First Analysis Forecasts (ILMN) www.americanbankingnews.com - April 27 at 11:08 AM
	Analysts Expect Illumina, Inc. (ILMN) to Announce $0.87 EPS www.americanbankingnews.com - April 27 at 8:48 AM
	Illumina (ILMN) Posts In-line Earnings in Q1, Margins Down - Yahoo Finance finance.yahoo.com - April 26 at 7:26 PM
	Edited Transcript of ILMN earnings conference call or presentation 25-Apr-17 9:00pm GMT finance.yahoo.com - April 26 at 7:26 PM
	Cancer start-up Grail added one of Silicon Valley's best-known biotech VCs to its board finance.yahoo.com - April 26 at 7:26 PM
	Illumina (ILMN) Receives Media Impact Score of 0.12 www.americanbankingnews.com - April 26 at 2:36 PM
	Illumina, Inc. (ILMN) Earns Outperform Rating from Cowen and Company www.americanbankingnews.com - April 26 at 12:47 PM
	Illumina, Inc. (ILMN) Releases Quarterly Earnings Results, Hits Estimates www.americanbankingnews.com - April 25 at 10:00 PM
	Illumina, Inc. (ILMN) Issues Q2 Earnings Guidance www.americanbankingnews.com - April 25 at 7:00 PM
	Illumina, Inc. (ILMN) Releases FY17 Earnings Guidance www.americanbankingnews.com - April 25 at 7:00 PM
	Illumina Inc. Profit Drops 11% In Q1 www.rttnews.com - April 25 at 5:23 PM
	Illumina Reports Financial Results for First Quarter of Fiscal Year 2017 finance.yahoo.com - April 25 at 5:23 PM
	Illumina meets 1Q profit forecasts marketbeat.com - April 25 at 4:21 PM
	Illumina, Inc. (ILMN) Given Consensus Recommendation of "Hold" by Brokerages www.americanbankingnews.com - April 25 at 2:51 PM
	There's Something Wrong With Illumina's Gene Sequencing Machine www.benzinga.com - April 24 at 5:34 PM
	Illumina (ILMN) Receives Daily Media Impact Score of 0.20 www.americanbankingnews.com - April 23 at 11:06 PM
	Should You Sell llumina (ILMN) Before Earnings? - Yahoo Finance finance.yahoo.com - April 22 at 8:09 AM
	3 Things to Look for in Illumina's Q1 Results finance.yahoo.com - April 22 at 8:09 AM
	3 Things to Look for in Illumina's Q1 Results www.fool.com - April 22 at 7:34 AM
	Should You Sell llumina (ILMN) Before Earnings? finance.yahoo.com - April 21 at 10:41 AM
	The Top Gene-Sequencing Stock to Buy in 2017 finance.yahoo.com - April 20 at 5:59 PM
	Technical Reports on Biotech Stocks -- CytRx, Achaogen, Jaguar Animal, and Illumina www.bizjournals.com - April 18 at 11:04 AM
	Illumina, Inc. (ILMN) Lifted to "Strong-Buy" at Vetr Inc. www.americanbankingnews.com - April 18 at 12:23 AM
	Positive Press Coverage Likely to Affect Illumina (ILMN) Share Price www.americanbankingnews.com - April 17 at 8:21 PM